Literature DB >> 18617898

Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice.

A Lespagnol1, D Duflaut, C Beekman, L Blanc, G Fiucci, J-C Marine, M Vidal, R Amson, A Telerman.   

Abstract

TSAP6 (tumor suppressor-activated pathway 6), also known as Steap3, is a direct p53 transcriptional target gene. It regulates protein secretion, for example translationally controlled tumor protein (TCTP), which is implicated in tumor reversion. In keeping with the latter, we show herein that TSAP6 is a glycosylated protein present in the trans-Golgi network, endosomal-vesicular compartment and cytoplasmic membrane. To further investigate the physiological function of TSAP6, we have generated TSAP6-deficient mice. These mice exhibit microcytic anemia with abnormal reticulocyte maturation and deficient transferrin receptor downregulation, a process known to be dependent on exosomal secretion. Moreover, we provide direct evidence that exosome production is severely compromised in TSAP6-null cells. Finally, we show that the DNA damage-induced p53-dependent nonclassical exosomal secretory pathway is abrogated in TSAP6-null cells. Given the fact that exosomes are used as cell-free vaccines against cancer and that they could be involved in the biogenesis and spread of human immunodeficiency virus, it is important to understand their regulation. The results presented here provide the first genetic demonstration that exosome formation is a tightly controlled biological process dependent of TSAP6.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617898     DOI: 10.1038/cdd.2008.104

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  127 in total

1.  Human STEAP3 mutations with no phenotypic red cell changes.

Authors:  Dun Liu; Sheng Yi; Xinhua Zhang; Ping Fang; Chenguang Zheng; Li Lin; Ren Cai; Yuhua Ye; Yuqiu Zhou; Yunhao Liang; Feng Cheng; Xuelian Zhang; Wanjun Zhou; Narla Mohandas; Xiuli An; Xiangmin Xu
Journal:  Blood       Date:  2015-12-16       Impact factor: 22.113

Review 2.  Tumor-derived exosomes in oncogenic reprogramming and cancer progression.

Authors:  Sarmad N Saleem; Asim B Abdel-Mageed
Journal:  Cell Mol Life Sci       Date:  2014-08-26       Impact factor: 9.261

Review 3.  Membrane vesicles as conveyors of immune responses.

Authors:  Clotilde Théry; Matias Ostrowski; Elodie Segura
Journal:  Nat Rev Immunol       Date:  2009-06-05       Impact factor: 53.106

Review 4.  Exosomes: a new weapon to treat the central nervous system.

Authors:  Luca Braccioli; Cindy van Velthoven; Cobi J Heijnen
Journal:  Mol Neurobiol       Date:  2013-07-16       Impact factor: 5.590

5.  Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin.

Authors:  James S Testa; Geraud S Apcher; Joseph D Comber; Laurence C Eisenlohr
Journal:  J Immunol       Date:  2010-11-03       Impact factor: 5.422

Review 6.  The emerging role of exosomes in survivin secretion.

Authors:  Salma Khan; Heather Ferguson Bennit; Nathan R Wall
Journal:  Histol Histopathol       Date:  2014-07-14       Impact factor: 2.303

7.  Senescence, apoptosis, and stem cell biology: the rationale for an expanded view of intracrine action.

Authors:  Richard N Re; Julia L Cook
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-10       Impact factor: 4.733

8.  Biological properties of extracellular vesicles and their physiological functions.

Authors:  María Yáñez-Mó; Pia R-M Siljander; Zoraida Andreu; Apolonija Bedina Zavec; Francesc E Borràs; Edit I Buzas; Krisztina Buzas; Enriqueta Casal; Francesco Cappello; Joana Carvalho; Eva Colás; Anabela Cordeiro-da Silva; Stefano Fais; Juan M Falcon-Perez; Irene M Ghobrial; Bernd Giebel; Mario Gimona; Michael Graner; Ihsan Gursel; Mayda Gursel; Niels H H Heegaard; An Hendrix; Peter Kierulf; Katsutoshi Kokubun; Maja Kosanovic; Veronika Kralj-Iglic; Eva-Maria Krämer-Albers; Saara Laitinen; Cecilia Lässer; Thomas Lener; Erzsébet Ligeti; Aija Linē; Georg Lipps; Alicia Llorente; Jan Lötvall; Mateja Manček-Keber; Antonio Marcilla; Maria Mittelbrunn; Irina Nazarenko; Esther N M Nolte-'t Hoen; Tuula A Nyman; Lorraine O'Driscoll; Mireia Olivan; Carla Oliveira; Éva Pállinger; Hernando A Del Portillo; Jaume Reventós; Marina Rigau; Eva Rohde; Marei Sammar; Francisco Sánchez-Madrid; N Santarém; Katharina Schallmoser; Marie Stampe Ostenfeld; Willem Stoorvogel; Roman Stukelj; Susanne G Van der Grein; M Helena Vasconcelos; Marca H M Wauben; Olivier De Wever
Journal:  J Extracell Vesicles       Date:  2015-05-14

Review 9.  The molecular programme of tumour reversion: the steps beyond malignant transformation.

Authors:  Adam Telerman; Robert Amson
Journal:  Nat Rev Cancer       Date:  2009-01-30       Impact factor: 60.716

10.  Excreted/secreted proteins from trypanosome procyclic strains.

Authors:  Celestine Michelle Atyame Nten; Nicolas Sommerer; Valerie Rofidal; Christophe Hirtz; Michel Rossignol; Gerard Cuny; Jean-Benoit Peltier; Anne Geiger
Journal:  J Biomed Biotechnol       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.